Glucotrack, Inc.·4

Oct 7, 7:26 PM ET

Goode Paul 4

4 · Glucotrack, Inc. · Filed Oct 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-25
Goode Paul
DirectorChief Executive Officer
Transactions
  • Other

    Common Stock, par value $0.001 per share

    2025-03-25+42339 total
Footnotes (1)
  • [F1]On October 7, 2022, the reporting person entered into an into Intellectual Property Purchase Agreement (the "IP Purchase Agreement") with Glucotrack, Inc. (the "Issuer"), pursuant to which the reporting person is entitled to certain specified milestone payments, payable in common stock, par value $0.001 per share, of the Issuer (the "Common Stock"), as set forth in the IP Purchase Agreement. Upon the achievement of the third milestone contemplated by the IP Purchase Agreement, the reporting person was issued 42 shares of Common Stock, pursuant to the terms of the IP Purchase Agreement.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT